Effect of intravenous lidocaine on pain after head and neck cancer surgery (ELICO trial): A randomised controlled trial
CONCLUSION
Intravenous lidocaine in ENT cancer surgery did not show any additional analgesic or morphine-sparing effect 48 h after surgery. Three to six months after surgery, there was no significant difference in pain scores or consumption of analgesics. Patients treated pre-operatively with opioids were not evaluated in the study.
TRIAL REGISTRATION
Clinicaltrials.gov identifier: NCT02894710 and EUDRACT number 2015-005799-90.
Source: European Journal of Anaesthesiology - Category: Anesthesiology Tags: Pain Source Type: research
More News: Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | ENT & OMF | Head and Neck Cancer | Lidoderm | Morphine | Pain | Study